B3GAT1 and cancer: The divergence between NK2 and the other subsets was also confirmed in blood from people with cancer, but the influence of the tumor on the distinction between the NK1, NK2 and NK3 subsets is stronger at the tumor bed than in the blood (Fig. 8a,b).